Literature DB >> 11726843

Accuracy of EUS in the evaluation of Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma.

I A Scotiniotis1, M L Kochman, J D Lewis, E E Furth, E F Rosato, G G Ginsberg.   

Abstract

BACKGROUND: Nonoperative therapy with intent to cure may be considered for patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma. However, a more advanced stage of disease must be precluded before such treatment. The potential of EUS for this purpose was evaluated.
METHODS: EUS was performed in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma based on endoscopy, endoscopic biopsies, and CT before esophagectomy. EUS findings were compared with surgical/pathologic evaluation.
RESULTS: EUS suggested submucosal invasion in 6 patients and lymph node involvement in 5 patients. By surgical/pathologic evaluation, 5 of 22 patients (23%) had unsuspected submucosal invasion and 1 had lymph node involvement. EUS detected all 5 instances of submucosal invasion and the single instance of lymph node involvement. EUS was falsely positive for submucosal invasion in 1 patient and for lymph node involvement in 4 patients. Sensitivity, specificity, and negative predictive values of preoperative EUS for submucosal invasion were 100%, 94%, and 100%, and for lymph node involvement were 100%, 81%, and 100%, respectively. A nodule or stricture noted by endoscopy was associated with an increased likelihood of submucosal invasion.
CONCLUSIONS: In patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma, EUS detected otherwise unsuspected submucosal invasion and lymph node involvement. Patients should be evaluated with EUS when nonoperative therapy is contemplated.

Entities:  

Mesh:

Year:  2001        PMID: 11726843     DOI: 10.1067/mge.2001.119216

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  21 in total

1.  S, m, l, xl.

Authors:  T Wang; G Triadafilopoulos
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 2.  Barrett's esophagus.

Authors:  Jeffrey H Peters; Jeffrey A Hagen; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

3.  Barrett's esophagus and the increasing role of endoluminal therapy.

Authors:  Michael S Smith; Charles J Lightdale
Journal:  Therap Adv Gastroenterol       Date:  2008-09       Impact factor: 4.409

Review 4.  Endoscopic therapy for Barrett's oesophagus.

Authors:  H Barr; N Stone; B Rembacken
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

5.  Endoscopic mucosal resection in the setting of Barrett's esophagus.

Authors:  Jason K Lee; Robert Enns
Journal:  Can J Gastroenterol       Date:  2007-03       Impact factor: 3.522

6.  [Endosonography of the gastrointestinal tract].

Authors:  M Moehler; P R Galle; R Kiesslich
Journal:  Chirurg       Date:  2007-05       Impact factor: 0.955

7.  Role of endoscopic ultrasound in gastrointestinal surgery.

Authors:  Biswanath P Gouda; Tarun Gupta
Journal:  Indian J Surg       Date:  2011-12-09       Impact factor: 0.656

8.  Radiofrequency ablation for Barrett's-associated intramucosal carcinoma: a multi-center follow-up study.

Authors:  Adam C Strauss; Agoston T Agoston; Parambir S Dulai; Amitabh Srivastava; Richard I Rothstein
Journal:  Surg Endosc       Date:  2014-12       Impact factor: 4.584

9.  Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial.

Authors:  A May; E Günter; F Roth; L Gossner; M Stolte; M Vieth; C Ell
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

10.  Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.

Authors:  Prashanthi N Thota; Alaa Sada; Madhusudhan R Sanaka; Sunguk Jang; Rocio Lopez; John R Goldblum; Xiuli Liu; John A Dumot; John Vargo; Gregory Zuccarro
Journal:  Surg Endosc       Date:  2016-07-21       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.